Sachetta’s Rein Therapeutics RNTX Stock Holding History

Sachetta’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	-$2.3K	–	1222
2024 Q4	$2.3K	Hold	1,000	–	–	﹤0.01%	791
2024 Q3	$3.54K	Buy	+1,000	New	+$2.67K	﹤0.01%	727

Other funds holding RNTX

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Sachetta's RNTX Position: Q1 2025 in Review

Sachetta sold out of Rein Therapeutics (RNTX) in Q1 2025, closing a stake of 1,000 shares — an estimated $2.3K sold.

Sachetta first reported a position in RNTX in Q3 2024 and held it in 2 quarters. The position peaked at $3.54K in Q3 2024. 39 funds tracked by Wall St. Rank hold RNTX as of Q1 2025.

Sachetta reported no remaining Rein Therapeutics position as of Q1 2025 after selling out during the quarter.
Sachetta sold 1,000 Rein Therapeutics shares in Q1 2025, an estimated $2.3K.
Sachetta first reported a position in Rein Therapeutics in Q3 2024 and held it in 2 quarters.
Sachetta's Rein Therapeutics position peaked at $3.54K in Q3 2024.
39 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2025.

Based on Sachetta's 13F filing for Q1 2025, filed 2 May 2025.